Abstract 9927: Helix B Surface Peptide, a Small Non-erythropoietic Molecule Based on the Erythropoietin Structure, Effectively Ameliorates the Progression of Chronic Heart Failure in the Rat Post Myocardial Infarction Model
Ismayil Ahmet(National Institute on Aging), Mark I. Talan(National Institute on Aging), Anthony Cerami(Araim Pharmaceuticals (United States)), Michael Brines(Northwell Health), Hyun‐Jin Tae(Jeonbuk National University), Edward G. Lakatta(Johns Hopkins University)
Cited by 0
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults
|Circulation|2005|1.2k
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises
|Circulation|2003|1.1k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k